IP Verse

Cytotoxicity-Inducing Therapeutic Agent - EP2647707B1

PatentPatent Analysis

EP2647707

CHUGAI SEIYAKU KABUSHIKI KAISHA
Application Number
EP11845786A
Filing Date
Nov 30, 2011
Status
Revoked
Aug 4, 2023
Grant Date
Sep 12, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3181581B1
EP3296395B2
EP3202785B1

Bibliography

The patent EP2647707B1 was granted to Chugai Seiyaku Kabushiki Kaisha on Sep 12, 2018 following the initial filing on Nov 30, 2011 under the application number EP11845786A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BOEHRINGER INGELHEIM RCV BOEHRINGER INGELHEIMJun 12, 2019ADMISSIBLE
GENMABJun 12, 2019ADMISSIBLE
JAMES POOLEJun 12, 2019ADMISSIBLE
MATHYS & SQUIREJun 12, 2019ADMISSIBLE
JANSSEN BIOTECHMay 24, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents